“Why Good Drugs Sometimes Fail in the Market” explained why a targeted cancer drug failed, despite evidence that it was effective. “Pharma Fails Credibility Test” challenged the world’s leading drugmakers to make a more serious move to disclose their clinical trial results, both from positive and negative studies. “Big Data is BS. When Will it Become Real?” debunked much of the present hype around big data in healthcare, while showing how it could be usefully applied in the future. “If You’ve Got a Real Breakthrough, the FDA Wants to Talk” was one of the first stories of the year that explained an important new change to drug regulatory policy at the FDA.
